Showing 105 of 105on this page. Filters & sort apply to loaded results; URL updates for sharing.105 of 105 on this page
Renowned Nobel Laureate Jean-Marie Lehn Appointed Chairman of Syndivia ...
Syndivia Raises €1M Investment to Advance Its Tumour Microenvironment ...
Syndivia | | The Pharmaletter
Mabqi & Syndivia announce the execution of an exclusive licensing ...
Syndivia – Making a difference in ADC with GeminiMab
GSK acquires exclusive rights from Syndivia for antibody drug conjugate ...
Syndivia In-Licenses DARx Technology for DAR1 ADC — Syndivia
GSK acquires exclusive rights from Syndivia for ADC | The Pharmaletter
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC ...
Syndivia Unveils New Clinical Asset Featuring Proprietary ADC Linker ...
GSK Licenses Pre-clinical mCRPC ADC From Syndivia
Here’s a glimpse into what we’ve been exploring at Syndivia over the ...
GSK partners with Syndivia for prostate cancer ADC | Hung Trinh posted ...
GSK acquires exclusive rights from Syndivia for ADC in prostate cancer
Syndivia 2026 Company Profile: Valuation, Funding & Investors | PitchBook
Syndivia posted on LinkedIn
GSK acquires exclusive rights from Syndivia for antibody-drug conjugate ...
Syndivia
Syndivia – Making a difference in ADC with GeminiMab™ and DAR1™
Syndivia – Making a difference in ADC with DAR1
Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies ...
Syndivia on LinkedIn: Syndivia teams up with TVM Capital Life Science ...
GSK adquiere derechos exclusivos de Syndivia para un ADC en cáncer de ...
News — Syndivia
French Tech : Cancer de la prostate, Syndivia s'allie à GSK - 18/11
Syndivia In-Licenses SATT Conectus' DARx Technology » ADC Review
Pharma. Cancer de la prostate: GSK noue s'allie avec Syndivia en ...
SYNDIVIA | Conectus
Syndivia : Capital Grand Est
TiPLab - Syndivia 的新型 ADC 位点特异性偶联技术 GeminiMab
Santé: Cancer de la prostate: GSK noue s'allie avec Syndivia en ...
Labo Syndivia - Plan dessiné par nowel
Oncologie : La biotech strasbourgeoise Syndivia cède les droits d'un ...
OneStart Europe 2015 Semi-finalist: Syndivia - Oleksandr Koniev - YouTube
Syndivia | LinkedIn
ADC Prostate Cancer: GSK acquires Syndivia’s preclinical cancer ...
GSK Secures Exclusive License to Syndivia’s ADC Candidate for Prostate ...
GSK secures exclusive rights to Syndivia’s preclinical ADC for advanced ...
GSK targets Syndivia’s prostate cancer ADC in £268m buy
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s ...
Christmas season has not yet ended for Syndivia! This month, we are ...
GSK buys Syndivia's ADC for prostate cancer in $357M deal | HealthCare ...
#worldadc #adc #syndivia | Sasha Koniev
Liposarcoma Pipeline 2025: Clinical Trials, Revenue Share, Medication ...
AbClon Secures Chinese Patent for Next-Generation ADC Technology – Archyde
INA03, a potent transferrin-competitive antibody-drug conjugate against ...
Scientific Poster: Development of an ADC Process with Single Use ...
2025 Aacr Horizon Lung
Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to ...
Dr JF Prost joins Mabqi leadership team as new Medical Director - Mabqi
Dna Transkripsjonsdiagram
Ahsen Seyrek: GSK Expands Its Oncology Pipeline with a New ADC for ...
"How dangerous it too Dangerous" Three cardinal rules for azide safety ...
GSK Buys Global Rights To Preclinical Cancer Therapy For $357M
Sasha Koniev on LinkedIn: LSX World Congress 2024
Faeth Therapeutics raises $25 million for cancer trials | Consort ...
Antibody-Vincristine Conjugates as Potent Anticancer Therapeutic Agents ...
Patronus AI Open Sources Glider: A 3B State-of-the-Art Small Language ...
Sasha Koniev on LinkedIn: #bio2024 #adc #biotech #geminimab
NVIDIA AI Releases UltraLong-8B: A Series of Ultra-Long Context ...
Sasha Koniev on LinkedIn: BIO-Europe Spring 2024
Nintendo Switch 2: New Mario Kart, features and more | Dr. Timos ...
Danish company pays $145M upfront to license nasal spray alternative to ...
Sarepta shares two-year DMD study data that could inform European ...
Samsung Galaxy Watch 7 has battery problem | Dr. Timos Papagatsias ...
Analogue’s 4K remake of the N64 is almost ready, and it’s a big deal ...
Sage nixes program for Parkinson’s disease after Phase 2 failure | Dr ...
Daily Telescope: Horsehead Nebula | Dr. Timos Papagatsias posted on the ...
Participations : Capital Grand Est
CD146-ts mAb (Syndivia)(CD146-ts mAb (Syndivia)) - 药物靶点：Muc18_专利_临床_研发
GSK携手Syndivia，共推新型ADC疗法，瞄准去势抵抗性前列腺癌新突破-问药网
Syndivia, la pépite strasbourgeoise qui a séduit le géant ...
Cancer de la prostate: GSK passe un accord avec la société française ...
#pharma #biotech #innovation #leadership #novartis #lonza #gsk # ...
MabDesign - Réseau industriel & expert des biothérapies
2.68亿英镑！GSK斩获前列腺癌ADC全球权益医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
摩熵医药(原药融云)-生物医药全产业链数据服务平台 | 摩熵医药生物医药数据库
Attentat au marché de Noël de Strasbourg : peine de 30 ans de réclusion ...
